- United States
- /
- Aerospace & Defense
- /
- NasdaqGS:AVAV
AeroVironment (AVAV) Shares Jumped, What Is Driving Attention Now?
AeroVironment (AVAV) has attracted fresh investor attention after a reported US$400 million U.S. Army production contract for its Locust directed energy counter drone system, alongside meaningful boardroom changes.
See our latest analysis for AeroVironment.
AeroVironment’s shares recently moved sharply higher, with a 1-day share price return of 9.12% and 30-day share price return of 29.15%. However, the year-to-date share price return is down 27.11% and the 1-year total shareholder return is down 23.61%. By contrast, the 3-year total shareholder return of 94.96% and 5-year total shareholder return of 86.30% point to a much stronger longer-term record. This context helps explain why investors are watching how the new Locust contract and board changes might influence the next phase of the story.
If the Locust contract has you thinking about other defense and autonomy opportunities, it could be a good moment to scan the market for 37 robotics and automation stocks.
AeroVironment’s sharp rebound and the fresh Locust contract push raise a clear puzzle. Has most of the easy upside already played out, or does the current valuation still leave meaningful room ahead for patient investors?
Most Popular Narrative: 25.9% Undervalued
AeroVironment’s most followed valuation narrative puts fair value at $251.93 a share versus the recent $186.73 close, which immediately raises questions about what assumptions sit underneath that gap.
AeroVironment's recent contract wins and rapid expansion into advanced areas like space-based laser communications and directed energy weapons position the company to capitalize on the persistent global shift toward defense modernization, addressing urgent demands among the U.S. and allied militaries, likely supporting sustained top-line revenue growth and backlog visibility over multiple years. The company's strategic focus on developing modular, interoperable, and software-defined platforms, including the newly launched AV Halo open software ecosystem, directly aligns with the accelerating adoption of AI-powered autonomy and network-centric warfare, enabling future premium pricing, increased service revenues, and gross margin expansion as these high-value platforms are deployed at scale.
Want to understand why this narrative assigns such a premium fair value to AeroVironment? The story leans heavily on rising cash generation, higher margins, and sizeable revenue expansion assumptions that are anything but conservative.
Result: Fair Value of $251.93 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, AeroVironment’s heavy reliance on U.S. defense contracts, along with pressure on margins after the BlueHalo acquisition, could quickly challenge this optimistic narrative.
Find out about the key risks to this AeroVironment narrative.
Another View: What AeroVironment’s Sales Multiple Is Saying
The analyst narrative and SWS fair value suggest AeroVironment is undervalued. The P/S picture is less straightforward. AVAV trades around 4.8x sales, which is in line with the US Aerospace & Defense average of 4.8x but well above the SWS fair ratio of 2.6x. That gap implies investors are already paying a premium for growth and contract visibility, so how much margin of safety is really left?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With AeroVironment sitting between upbeat growth narratives and a rich sales multiple, now is a good time to review the underlying data yourself and act on your own judgement based on the 2 key rewards and 1 important warning sign.
Looking for more AeroVironment investment ideas?
If AeroVironment has sharpened your focus on opportunity, do not stop here. Use objective screeners to spot other ideas before they move out of reach.
- Target potential mispricings by scanning for companies that look attractively valued on both quality and fundamentals through the 52 high quality undervalued stocks.
- Strengthen your core holdings by focusing on companies with resilient finances using the solid balance sheet and fundamentals stocks screener (48 results).
- Get ahead of the crowd by hunting for smaller companies with strong fundamentals through the screener containing 21 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:AVAV
AeroVironment
A defense technology provider, designs, develops, produces, delivers, and supports a portfolio of robotic systems and related services for government agencies and businesses in the United States and internationally.
Reasonable growth potential with adequate balance sheet.
Similar Companies
Market Insights
Weekly Picks

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Why Amdocs is a high conviction Buy for me?
Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend
Recently Updated Narratives
High-Growth Emerging Commercial Stage Biotech

ALL ABOARD THE VALUE TRAIN: WHY $RAIL MIGHT BE HEADED NORTH - FREIGHTCAR AMERICA - Long term price target of $25

Capitalizing on rising semiconductor complexity
Popular Narratives



